Memory Pharmaceuticals' IPO

Memory Pharmaceuticals raised a round of funding on April 05, 2004. Investors include Public.

Memory Pharmaceuticals Corp., a publicly traded biopharmaceutical company, focuses on developing drugs for the treatment of CNS disorders such as Alzheimer's disease, schizophrenia, depression and bip…

Articles about Memory Pharmaceuticals' IPO: